Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Denis

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxelC D Britten, S D Baker, L J Denis, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
European School of Oncology Advisory report to the European Commission for the "Europe Against Cancer Programme" European Code Against CancerP Boyle, U Veronesi, M Tubiana, et al.
Progress in Clinical and Biological Research|January 1, 1984
Early adjuvant adriamycin in superficial bladder carcinomaC C Schulman, L J Denis, W Costerlinck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors. European Organization for Research and Treatment of Cancer Early Clinical Studies GroupF A Eskens, G A Greim, C van Zuylen, et al.
BJU International|February 27, 2004
The story of the European Randomized Study of Screening for Prostate CancerF H Schröder, L J Denis, M Roobol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancerN C Levitt, F A Eskens, K J O'Byrne, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxelC D Britten, S D Baker, L J Denis, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
European School of Oncology Advisory report to the European Commission for the "Europe Against Cancer Programme" European Code Against CancerP Boyle, U Veronesi, M Tubiana, et al.
Progress in Clinical and Biological Research|January 1, 1984
Early adjuvant adriamycin in superficial bladder carcinomaC C Schulman, L J Denis, W Costerlinck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors. European Organization for Research and Treatment of Cancer Early Clinical Studies GroupF A Eskens, G A Greim, C van Zuylen, et al.
BJU International|February 27, 2004
The story of the European Randomized Study of Screening for Prostate CancerF H Schröder, L J Denis, M Roobol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancerN C Levitt, F A Eskens, K J O'Byrne, et al.
Pageof 5